LOW-DOSE CHYMOTRYPSIN TREATMENT INHIBITS NEUTROPHIL MIGRATION INTO SITES OF INFLAMMATION INVIVO - EFFECTS ON MAC-1 AND MEL-14 ADHESION PROTEIN EXPRESSION AND FUNCTION

被引:94
作者
JUTILA, MA
KISHIMOTO, TK
FINKEN, M
机构
[1] STANFORD UNIV, DEPT PATHOL, STANFORD, CA 94305 USA
[2] VET ADM MED CTR, PALO ALTO, CA 94304 USA
关键词
CELL-SURFACE MOLECULE; NODE HOMING RECEPTOR; MONOCLONAL-ANTIBODY; LEUKOCYTE ADHESION; POLYMORPHONUCLEAR LEUKOCYTES; GLYCOPROTEIN FAMILY; ADHERENCE; ENDOTHELIUM; LYMPHOCYTES; LFA-1;
D O I
10.1016/0008-8749(91)90019-8
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Antibody blocking studies in the mouse suggest that the MEL-14 antigen is involved in neutrophil-endothelial cell interactions and may be important in neutrophil extravasation to sites of inflammation in vivo. We recently showed that chemotactic factor activation causes a rapid (within minutes) shedding of a large fragment of the MEL-14 antigen from the surface of neutrophils. We report here that chymotrypsin, at low doses (0.1 units/1 × 106 cells), but not trypsin, elastase, or collagenase, causes an activation-independent rapid loss (>90%) of the MEL-14 antigen from the surface of murine neutrophils. Under the same treatment conditions chymotrypsin has no effect on the expression of four other neutrophil surface antigens, including the Mac-1 adhesion protein. Chymotrypsin treatment has no effect on neutrophil adhesion to plastic, migration to C5a, or regulation of the Mac-1 antigen, but causes a greater than 95% reduction in neutrophil binding to high endothelial venules (HEV) in peripheral lymph nodes measured in the ex vivo frozen section HEV binding assay. The level of inhibition of neutrophil adhesion to HEV was comparable to that seen with the MEL-14 antibody. This experimental system allows us for the first time to specifically examine the consequences of removing the MEL-14 antigen from the surface of neutrophils on function in vivo. We show that treatment with chymotrypsin blocks >85% of the ability of neutrophils injected back into the animal to home to the inflamed peritoneum. In similar in vivo experiments the MEL-14 antibody blocks neutrophil homing by 60-70%. These results further support the importance of the MEL-14 antigen in neutrophil extravasation in vivo and indicate that chymotrypsin could be useful in examining the molecular mechanisms involved in extravasation of leukocytes into a variety of diverse tissue sites of inflammation. © 1991.
引用
收藏
页码:201 / 214
页数:14
相关论文
共 37 条
  • [1] THE SEVERE AND MODERATE PHENOTYPES OF HERITABLE MAC-1, LFA-1 DEFICIENCY - THEIR QUANTITATIVE DEFINITION AND RELATION TO LEUKOCYTE DYSFUNCTION AND CLINICAL-FEATURES
    ANDERSON, DC
    SCHMALSTEIG, FC
    FINEGOLD, MJ
    HUGHES, BJ
    ROTHLEIN, R
    MILLER, LJ
    KOHL, S
    TOSI, MF
    JACOBS, RL
    WALDROP, TC
    GOLDMAN, AS
    SHEARER, WT
    SPRINGER, TA
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1985, 152 (04) : 668 - 689
  • [2] LEUKOCYTE ADHESION DEFICIENCY - AN INHERITED DEFECT IN THE MAC-1, LFA-1, AND P150,95 GLYCOPROTEINS
    ANDERSON, DC
    SPRINGER, TA
    [J]. ANNUAL REVIEW OF MEDICINE, 1987, 38 : 175 - 194
  • [3] ANDERSON DC, 1986, J IMMUNOL, V137, P15
  • [4] ARFORS KE, 1987, BLOOD, V69, P338
  • [5] HOMING RECEPTORS AND VASCULAR ADDRESSINS - CELL-ADHESION MOLECULES THAT DIRECT LYMPHOCYTE TRAFFIC
    BERG, EL
    GOLDSTEIN, LA
    JUTILA, MA
    NAKACHE, M
    PICKER, LJ
    STREETER, PR
    WU, NW
    ZHOU, D
    BUTCHER, EC
    [J]. IMMUNOLOGICAL REVIEWS, 1989, 108 : 5 - 18
  • [6] INTERLEUKIN-1 ACTS ON CULTURED HUMAN VASCULAR ENDOTHELIUM TO INCREASE THE ADHESION OF POLYMORPHONUCLEAR LEUKOCYTES, MONOCYTES, AND RELATED LEUKOCYTE CELL-LINES
    BEVILACQUA, MP
    POBER, JS
    WHEELER, ME
    COTRAN, RS
    GIMBRONE, MA
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1985, 76 (05) : 2003 - 2011
  • [7] ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE-1 - AN INDUCIBLE RECEPTOR FOR NEUTROPHILS RELATED TO COMPLEMENT REGULATORY PROTEINS AND LECTINS
    BEVILACQUA, MP
    STENGELIN, S
    GIMBRONE, MA
    SEED, B
    [J]. SCIENCE, 1989, 243 (4895) : 1160 - 1165
  • [8] BUTCHER EC, 1979, J IMMUNOL, V123, P1996
  • [9] LEU-8 TQ1 IS THE HUMAN EQUIVALENT OF THE MEL-14 LYMPH-NODE HOMING RECEPTOR
    CAMERINI, D
    JAMES, SP
    STAMENKOVIC, I
    SEED, B
    [J]. NATURE, 1989, 342 (6245) : 78 - 82
  • [10] COLDITZ IG, 1985, SURV SYN PATHOL RES, V4, P44